Cargando…

Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer

BACKGROUND: Tumor mutation burden (TMB), DNA mismatch repair deficiency (dMMR), microsatellite instability (MSI), and PD‐L1 amplification (PD‐L1 AMP) may predict the efficacy of the PD‐1/PD‐L1 blockade. With the broadening landscape of immunotherapy use, it is important to identify patients who are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zang, Yuan‐sheng, Dai, Chun, Xu, Xiaoman, Cai, Xin, Wang, Guan, Wei, Jinwang, Wu, Angela, Sun, Wending, Jiao, Shunchang, Xu, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712454/ https://www.ncbi.nlm.nih.gov/pubmed/31270941 http://dx.doi.org/10.1002/cam4.2381

Ejemplares similares

Comprehensive analysis of age‐related somatic mutation profiles in Chinese young lung adenocarcinoma patients
por: Yang, Bo, et al.
Publicado: (2019)

Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
por: Duan, Jingjing, et al.
Publicado: (2018)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study
por: Cui, Pengfei, et al.
Publicado: (2018)

Tryptophan metabolism and disposition in cancer biology and immunotherapy
por: Badawy, Abdulla A.-B.
Publicado: (2022)

Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors
por: Li, Jiaping, et al.
Publicado: (2020)

Metabolomics and microbiome profiling as biomarkers in obstructive sleep apnoea: a comprehensive review
por: Zhang, Xiaoman, et al.
Publicado: (2021)

Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non‐small cell lung cancer
por: Zhao, Qian, et al.
Publicado: (2021)

Comprehensive assessment of the association between XPC rs2228000 and cancer susceptibility based on 26835 cancer cases and 37069 controls
por: Dai, Yingqi, et al.
Publicado: (2019)

Integration of comprehensive genomic profiling, tumor mutational burden, and PD‐L1 expression to identify novel biomarkers of immunotherapy in non‐small cell lung cancer
por: Shi, Yunfei, et al.
Publicado: (2021)

Comprehensive analysis of long noncoding RNA and mRNA in five colorectal cancer tissues and five normal tissues
por: Zhou, Zhen-Xu, et al.
Publicado: (2020)

Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
por: Pinter, Matthias, et al.
Publicado: (2017)

In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma
por: Lvu, Wen, et al.
Publicado: (2020)

Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential
por: Hu, Jing, et al.
Publicado: (2019)

Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis
por: Xu, He, et al.
Publicado: (2020)

T-cell response to checkpoint blockade immunotherapies: from fundamental mechanisms to treatment signatures
por: Elliot, Thomas A.E., et al.
Publicado: (2023)

Comprehensive analysis of the effect of rs2295080 and rs2536 polymorphisms within the mTOR gene on cancer risk
por: Qi, Guang-Hui, et al.
Publicado: (2020)

Screening and identification of LMNB1 and DLGAP5, two key biomarkers in gliomas
por: Zhou, Ding, et al.
Publicado: (2021)

The interleukin-18 gene promoter -607 A/C polymorphism contributes to non-small-cell lung cancer risk in a Chinese population
por: Jia, Youchao, et al.
Publicado: (2016)

Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
por: Chu, Ling-Yu, et al.
Publicado: (2021)

Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma
por: Zhang, Yue, et al.
Publicado: (2022)

Tumour-associated macrophages as a potential target to improve natural killer cell-based immunotherapies
por: Kitamura, Takanori
Publicado: (2023)

Checkpoint therapeutic target database (CKTTD): the first comprehensive database for checkpoint targets and their modulators in cancer immunotherapy
por: Zhang, Yixiao, et al.
Publicado: (2020)

Comprehensive characterization of cancer‐testis genes in testicular germ cell tumor
por: Chang, Yuting, et al.
Publicado: (2019)

Relationship between MEG3 gene polymorphism and risk of gastric cancer in Chinese population with high incidence of gastric cancer
por: Kong, Xiaoling, et al.
Publicado: (2020)

Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Chen, Junhui, et al.
Publicado: (2021)

Pretreatment lactate dehydrogenase may predict outcome of advanced non small‐cell lung cancer patients treated with immune checkpoint inhibitors: A meta‐analysis
por: Zhang, Zhibo, et al.
Publicado: (2019)

Correlation of preclinical and clinical biomarkers with efficacy and toxicity of cancer immunotherapy
por: Zheng, Lin-Peng, et al.
Publicado: (2023)

Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Liu, Yin-Qiao, et al.
Publicado: (2022)

A comprehensive and perspective view of oncoprotein SET in cancer
por: Bayarkhangai, Buuvee, et al.
Publicado: (2018)

Adoptive T Cell Immunotherapy for Cancer
por: Perica, Karlo, et al.
Publicado: (2015)

Interferon gamma in cancer immunotherapy
por: Ni, Ling, et al.
Publicado: (2018)

Comprehensive characterization of circular RNAs in ~ 1000 human cancer cell lines
por: Ruan, Hang, et al.
Publicado: (2019)

Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications
por: Zhao, Weihong, et al.
Publicado: (2014)

RRM1 *151A>T, RRM1 ‐756T>C, and RRM1 ‐585T>Gis associated with increased susceptibility of lung cancer in Chinese patients
por: Xu, Xiao‐Ling, et al.
Publicado: (2016)

Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis
por: Ye, Zu‐Lu, et al.
Publicado: (2019)

The genomic mutation spectrums of breast fibroadenomas in Chinese population by whole exome sequencing analysis
por: Xie, Shang‐Nao, et al.
Publicado: (2019)

Up-regulated microRNA-33b inhibits epithelial–mesenchymal transition in gallbladder cancer through down-regulating CROCC
por: Xu, Guohui, et al.
Publicado: (2020)

Characterization of lncRNA LINC00520 and functional polymorphisms associated with breast cancer susceptibility in Chinese Han population
por: Guo, Qiaoyun, et al.
Publicado: (2020)

Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901)
por: Peng, Wenying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p4j9gif0ldk4r9bvjrffo1doo5